Evolent Health (EVH) Capital Expenditures (2015 - 2026)

Evolent Health's Capital Expenditures history runs 12 years deep, the most recent figure standing at $6.4 million for Q1 2026.

• In Q1 2026, Capital Expenditures fell 25.47% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $31.9 million (up 13.35% YoY), while the FY2025 annual figure was $34.1 million, up 36.94% from the prior year.
• Capital Expenditures was $6.4 million for Q1 2026 at Evolent Health, down from $7.8 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $10.7 million in Q4 2022 to a low of $5.3 million in Q1 2024.
• Historically, Capital Expenditures has averaged $7.8 million across 5 years, with a median of $7.8 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Capital Expenditures jumped 65.79% in 2022, then slumped 43.67% in 2023.
• A 5-year view of Capital Expenditures shows it stood at $10.7 million in 2022, then plunged by 43.67% to $6.1 million in 2023, then grew by 1.64% to $6.2 million in 2024, then climbed by 26.17% to $7.8 million in 2025, then fell by 17.46% to $6.4 million in 2026.
• The last three Capital Expenditures figures came in at $6.4 million (Q1 2026), $7.8 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.